Papers - Kawakami, Yutaka

Possible involvement of allogeneic antigens recognized by donor-derived CD4+ cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.

Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H ,Fujita T, Okamoto S, Ikeda Y and Kawakami Y.

British journal of Heamatology 132 ( 1 ) 56-65 2006.01

Research paper (scientific journal), Joint Work

Identification of a antigen, GARC-1, using cytotoxic T lymphocytes induced by HSV cancer vaccine

Iizuka Y, Kojima H, Kobata T, Kawase T, Kawakami Y and Toda M

International journal of Cancer 118 ( 4 ) 942-949 2006.02

Research paper (scientific journal), Joint Work

Autoantidoby to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism

M.Nakamura, Y. Tanaka, T. Satoh, M. Kawai, M. Hirakata, J.Kaburaki, Y. Kawakami, Y. Ikeda and M. Kuwana

Reumatology 45 ( 2 ) 150-156 2006.02

Research paper (scientific journal), Joint Work

A new melanoma antigen FABP7 involved in proliferation and invasion is a potential target for immunotherapy and molecular target therapy.

Goto Y, Matsuzaki Y, Kurihara S, Shimizu A, Okada T, Yamamoto K, Murata H, Takata M, Aburatani H, Hoon D, Saida T, Kawakami Y.

Cancer Res. 66 ( 8 ) 4443-4449 2006.04

Research paper (scientific journal), Joint Work

Increase in Circulating Endothelial Precursors by Atorvastain in Patients With Systemic Sclerosis.

Kuwana M, Kaburaki J, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y,

Arthritis & Pheumatism. 54 ( 6 ) 1946-1951 2006.06

Research paper (scientific journal), Joint Work

The BRAF-MAPK signaling pathway is essential for cancer immune evasion in human melanoma cells.

Sumimoto H, Imabayashi F, Iwata T, Kawakami Y.

J Exp Med. 203 ( 7 ) 1651-1656 2006.07

Research paper (scientific journal), Joint Work

Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi.

Sumimoto Hidetoshi, Hirata K, Yamagata S, Miyoshi H, Miyagishi M, Taira K and Kawakami Yutaka

International Journal of Cancer 118 ( 2 ) 472-476 2006.01

Research paper (scientific journal), Joint Work

Neurogenic potential of Progenitors derived from human circulating CD14+ monocytes.

Kodama H, Inoue T, Watanabe R, Yasutomi D, Kawakami Y, Ogawa S, Mikoshiba K, Ikeda Y, Kuwana M.

Immunology and Cell Biology. 84 ( 2 ) 209-217 2006.04

Research paper (scientific journal), Joint Work

Frequent immune response to a melanocyte-specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.

Ohtani S, Sakurai T, Yamamoto K, Fujita T, Matsuzaki Y, Goto Y, Ando Y, Suzuki S, Usui M, Takeuchi M, Kawakami Y .

Br J Ophthalmol. 90 ( 6 ) 773-777 2006.06

Research paper (scientific journal), Joint Work

Analysis of the tumor reactivity of tumor-infiltrating lymphocytes in a metastatic melanoma lesion that lost MHC class I expression after anti-PD-1 therapy.

Inozume T, Yaguchi T, Ariyasu R, Togashi Y, Ohnuma T, Honobe A, Nishikawa H, Kawakami Y, Kawamura T.

J Invest Dermatol. pii: S0022-202X(19)30023-5 2019.01

Research paper (scientific journal), Joint Work

A defined commensal consortium induces CD8 T cells and anti-cancer immunity.

Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, Narushima S, Vlamakis H, Motoo I, Sugita K, Shiota A, Takeshita K, Yasuma K, Riethmacher D, Kaisho T, Norman JM, Mucida D, Suematsu M, Yaguchi T, Bucci V, Inoue T, Kawakami Y, Olle B, Roberts B, Hattori M, Xavier RJ, Atarashi K, Honda K.

Nature. 565 ( 7741 ) 600 - 605 2019.01

Research paper (scientific journal), Joint Work

Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice.

Mukai S, Ogawa Y, Urano F, Kawakami Y, Tsubota K.

R Soc Open Sci. 5 ( 10 ) 181067 2018.10

Research paper (scientific journal), Joint Work

Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice.

Mukai S, Ogawa Y, Saya H, Kawakami Y, Tsubota K.

PLOS ONE. 13 ( 10 ) e0203742 2018.10

Research paper (scientific journal), Joint Work

Inhibition of Vascular Adhesion Protein-1 for Treatment of Graft-Versus-Host Disease in Mice.

Mukai S, Ogawa Y, Kawakami Y, Mashima Y, Tsubota K.

FASEB J. 32 ( 8 ) 4085 - 4095 2018.08

Research paper (scientific journal), Joint Work

Carboplatin and epirubicin combination therapy for advanced malignant epithelial skin tumors: retrospective study of six patients.

Nakaymura Y, Tanase K, Hirai I, Kawakami Y, Funakoshi T

The Journal of Dermatology 45 ( 7 ) 874 - 875 2018.07

Research paper (scientific journal), Joint Work

Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.

Matsuda T,Takeuchi H, Sakurai T, Mayanagi S, Booka E, Fujita T, Higuchi H, Taguchi J, Hamamoto Y, Takaishi H, Kawakubo H, Okamoto M, Sunamura M, Kawakami Y, Kitagawa Y.

oncology letters. 16 ( 1 ) 1348 - 1356 2018.07

Research paper (scientific journal), Joint Work

Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.

Hazama S, Tamada K, Yamaguchi Y, Kawakami Y, Nagano H.

Annals of Gastroenterological Surgery 2 ( 4 ) 289 - 303 2018.06

Research paper (scientific journal), Joint Work

Evaluation of the appropriate surgical margin for pigmented basal cell carcinoma according to the risk factors for recurrence: a single-institute retrospective study in Japan.

Nakamura Y, Tanese K, Hirai I, Kameyama K, Kawakami Y, Amagai M, Funakoshi T.

J Eur Acad Dermatol Venereol. [Epub ahead of print] 2018.05

Research paper (scientific journal), Joint Work

Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms.

Ahmed Hegab, Mari Ozaki, Kagawa Shizuko, Junko Hamamoto, Hiroyuki Yasuda, Katsuhiko Naoki, Kenzo Soejima, Yongjun Yin, Tomonari Kinoshita, Tomonori Yaguchi, Yutaka Kawakami, David Orntiz, and Tomoko Betsuyaku.

Lung Cancer. 119   25 - 35 2018.05

Research paper (scientific journal), Joint Work

IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.

Kanekiyo S, Hazama S, Takenouchi H, Nakajima M, Shindo Y, Matsui H, Tokumitsu Y, Tomochika S, Tsunedomi R, Tokuhisa Y, Iida M, Sakamoto K, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Okuno K, Udaka K, Kawakami Y, Matsueda S, Ito K, Nagano H.

Oncol Rep. 39 ( 5 ) 2385 - 2392 2018.05

Research paper (scientific journal), Joint Work